Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Yongfei Cai(Boston Children's Hospital), Bing Chen(Xinjiang Academy of Agricultural and Reclamation Science), Sarah M. Sterling(Harvard University), Richard M. Walsh(Harvard University), Wei Yang(Chinese Academy of Sciences), Shaun Rawson(Harvard University), Hanqin Peng(Boston Children's Hospital), Christy L. Lavine(Beth Israel Deaconess Medical Center), Duane R. Wesemann(Brigham and Women's Hospital), Krishna Anand(Institute for Protein Innovation), Jianming Lü(Guangzhou First People's Hospital), Sophia Rits‐Volloch(Boston Children's Hospital), Haisun Zhu(Institute for Protein Innovation), Tianshu Xiao(Nanyang Technological University), Pei Tong, Michael S. Seaman(Beth Israel Deaconess Medical Center), Avneesh Gautam(Brigham and Women's Hospital), Shen Lu(Codex Biosolutions (United States)), Jun Zhang(Harvard University)
Cited by 254
Related Papers
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Distinct conformational states of SARS-CoV-2 spike protein
|Science|2020|1.4k
The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue
|Proceedings of the National Academy of Sciences|2003|737